Genmab reported DKK22.72B in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Amarin AMRN:US $ 641.11M 25.99M
Amgen AMGN:US $ 916M 5784M
Artemis Alpha ATS:LN 159.16M 22.66M
AstraZeneca AZN:LN 36340M 2928M
Bayer BAYN:GR € 37437M 4417M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Exelixis EXEL:US $ 2293.85M 83.24M
Fresenius Medical Care FME:GR € 13234.5M 535.71M
Galapagos GLPG:NA € 2646.59M 3.23M
Genmab GEN:DC DK 22719M 523M
GlaxoSmithKline GSK:LN 16181M 1126M
GN Store Nord GN:DC DK 6016M 213M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 18.45B 167M
Hikma Pharmaceutical HIK:LN 2.45B 163M
Immunogen IMGN:US $ 306.47M 19.12M
Insmed INSM:US $ 119.88M 290.59M
Lonza Group LONN:SW 9.75B 2.48B
Merck MRK:GR € 22919M 1581M
Novartis NOVN:VX SF 61540M 6115M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
William Demant Holding WDH:DC 7.98B 213M